Measles laboratory findings

Measles Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Measles from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Measles laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Measles laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Measles laboratory findings

CDC on Measles laboratory findings

Measles laboratory findings in the news

Blogs on Measles laboratory findings

Directions to Hospitals Treating Measles

Risk calculators and risk factors for Measles laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:  Alejandro Lemor, M.D. [2]

## Overview

[edit | edit source]

Laboratory confirmation is essential for all sporadic measles cases and all outbreaks. Detection of measles-specific IgM antibody and measles RNA by real-time polymerase chain reaction (RT–PCR) are the most common methods for confirming measles infection. Healthcare providers should obtain both a serum sample and a throat swab (or nasopharyngeal swab) from patients suspected to have measles at first contact with them. Urine samples may also contain virus, and when feasible to do so, collecting both respiratory and urine samples can increase the likelihood of detecting measles virus. [1]

## Laboratory Findings

[edit | edit source]

* In a CBC it is possible to find leukopenia, lymphopenia and thrombocytopenia.
* Measles is a disease best diagnosed clinically, however laboratory tests have a limited role to play especially in those conditions where the diagnosis is uncertain and certain cases of atypical pneumonia.
* A positive laboratory finding is defined as at least 4 fold increase in antibody titer, or isolation of measles virus or presence of measles-specific IgM antibodies.[2]

### Serology

[edit | edit source]

Detection of specific IgM antibodies in a serum sample collected within the first few days of rash onset can provide presumptive evidence of a current or recent measles virus infection. However, because no assay is 100% specific, serologic testing of non-measles cases using any assay will occasionally produce false positive IgM results.

In countries such as the United States where endemic circulation of measles has been eliminated, most suspected cases are not measles, and rash and fever illnesses are more likely due to a number of other rash–causing illnesses such as parvovirus B19, enteroviruses, or human herpes virus–6 (roseola). In addition, testing for measles is frequently requested for people with ear infections or sore throats who were given antibiotics which resulted in a rash. The presence of rheumatoid factor can also result in a false positive IgM. However, ongoing measles activity in many other countries will result in sporadic cases of measles in the United States.

In cases of measles infection following secondary vaccine failure IgM antibody may not be present. In these cases serological confirmation may be made by showing IgG antibody rises by Enzyme immunoassay or complement fixation. IgM antibodies are tested in a blood sample taken at least 4-5 days after appearance of rash and persist for 30-60 days thereafter. False positives are sometimes seen. More than 4 fold rise in IgG antibodies between actue and convalescent phase sera, is also diagnostic.

### Specimens for Detection of Measles RNA by RT–PCR or Virus Isolation

[edit | edit source]

Detection of measles RNA in a clinical sample can provide laboratory confirmation of infection. Real–time RT–PCR (rRT–PCR) and conventional, endpoint RT–PCR to detect measles RNA are performed at CDC. The rRT–PCR is more sensitive than endpoint RT–PCR assay for detection of measles RNA in clinical sample, while the endpoint assay is routinely used to amplify the region of the measles genome required to determine the genotype.

Throat (oropharyngeal), nasal or nasopharyngeal swabs are the preferred samples for virus isolation or detection of measles RNA by RT–PCR. Synthetic swabs are recommended. Urine samples may also contain virus and when feasible to do so, collection of both samples can increase the likelihood of detecting the virus. Collect samples as soon after rash as possible. The sample should be collected at the first contact with a suspected case of measles when the serum sample for diagnosis is drawn.

Detection of measles RNA and measles virus isolation are most successful when samples are collected on the first day of rash through the 3 days following onset of rash. However, virus may still be recovered by cell culture through day 10 following rash onset. Detection of measles RNA by [[[Real-time polymerase chain reaction|RT–PCR]] may be successful as late as 10–14 days post rash onset.

## References

[edit | edit source]

1. ↑ "CDC Measles Laboratory Findings".
2. ↑ "WHO GUIDELINES FOR EPIDEMIC PREPAREDNESS AND RESPONSE TO MEASLES OUTBREAKS".

Template:WH Template:WS